CHARACTERISTICS OF BACTERIAL COINFECTION IN COVID-19 PATIENTS AT HOI SUC COVID-19 HOSPITAL

Phương Mai Lê1,, Thiên Phú Trương1, Trọng Tín Trần1, Thị Nam Phương Nguyễn1, Thị Mỹ Duyên Trần1, Quang Tín Nguyễn1, Anh Tuấn Đặng1, Văn Thành Nguyễn1, Tuấn Khanh Tạ1, Tuấn Anh Nguyễn1
1 Cho Ray Hospital

Main Article Content

Abstract

Object: Describe the characteristics of co-infection and the cumulative antimicrobial susceptibility data in COVID-19 patients at the Hoi Suc COVID-19 hospital. Study subjects: Microbiology data at the Hoi Suc COVID-19 hospital from  01/09/2021 to 31/01/2022. Method: A descriptive cross-sectional study. Results: The proportion of COVID-19 patients with bacterial co-infection was 58.8% (705/1200). The first common types co-infections recorded was respiratory infections accounted for 74.5% (525/705). A total of 843 pathogenic bacteria strains were isolated, of which mainly Gram-negative bacilli with Acinetobacter baumannii accounted for the highest rate of 35.2% (303/843). The cumulative antimicrobial susceptibility data of Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa showed a susceptibility rate under 20% to most antibiotics. Conclusion: More than 50% of severe and critical COVID-19 had bacterial co-infection. The most common infections was respiratory tract infection. The bacteria were less susceptible to commonly used antibiotics.

Article Details

References

1. Organization WH. Novel Coronavirus (2019-nCoV): situation report, 1 [Internet]. Geneva PP - Geneva: World Health Organization; Available from: https://apps.who.int/iris/handle/10665/330760
2. Westblade LF, Simon MS, Satlin MJ. Bacterial Coinfections in Coronavirus Disease 2019. Trends Microbiol. 2021 Oct;29(10):930–41.
3. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). 2020 Feb;395(10223):507–13.
4. Garcia-Vidal C, Moreno-García E, Hernández-Meneses M, Puerta-Alcalde P, Chumbita M, Garcia-Pouton N, et al. Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2022 Jan;74(1):127–32.
5. Shafran N, Shafran I, Ben-Zvi H, Sofer S, Sheena L, Krause I, et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep. 2021 Jun;11(1):12703.
6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020 Mar;395(10229):1054–62.
7. Elabbadi A, Turpin M, Gerotziafas GT, Teulier M, Voiriot G, Fartoukh M. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia. Vol. 49, Infection. Germany; 2021. p. 559–62.